Zimmer Biomet (ZBH) Competitors

Zimmer Biomet (NYSE:ZBH) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Which has better valuation & earnings, ZBH or SOLV?

Zimmer Biomet has higher earnings, but lower revenue than Solventum.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.60B	2.83	$1.02B	$5.26	20.55
Solventum	$8.26B	1.43	N/A	N/A	N/A

Is ZBH or SOLV more profitable?

Zimmer Biomet has a net margin of 14.27% compared to Solventum's net margin of 0.00%. Zimmer Biomet's return on equity of 12.95% beat Solventum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	14.27%	12.95%	7.55%
Solventum	N/A	N/A	N/A

Do insiders & institutionals have more ownership in ZBH or SOLV?

88.9% of Zimmer Biomet shares are owned by institutional investors. 1.0% of Zimmer Biomet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate ZBH or SOLV?

Zimmer Biomet currently has a consensus price target of $123.28, suggesting a potential upside of 14.06%. Solventum has a consensus price target of $68.29, suggesting a potential downside of 0.46%. Given Zimmer Biomet's stronger consensus rating and higher possible upside, research analysts plainly believe Zimmer Biomet is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	11 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.25
Solventum	1 Sell rating(s)	9 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media prefer ZBH or SOLV?

In the previous week, Zimmer Biomet had 8 more articles in the media than Solventum. MarketBeat recorded 22 mentions for Zimmer Biomet and 14 mentions for Solventum. Solventum's average media sentiment score of 1.29 beat Zimmer Biomet's score of 0.85 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	11 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Solventum	10 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor ZBH or SOLV?

Zimmer Biomet received 899 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 67.21% of users gave Zimmer Biomet an outperform vote while only 5.56% of users gave Solventum an outperform vote.

Company	Underperform	Outperform
Zimmer Biomet	Outperform Votes 900 67.21%	Underperform Votes 439 32.79%
Solventum	Outperform Votes 1 5.56%	Underperform Votes 17 94.44%

Summary

Zimmer Biomet beats Solventum on 12 of the 14 factors compared between the two stocks.